Skip to Content

Research and Education

The Wien Center is recognized for its contributions to the international body of research related to Alzheimer’s disease and other dementias. Due to Mount Sinai’s many connections to other facilities and organizations, the Wien Center’s patients have greater opportunities to participate in clinical trials, research studies, and tissue donation programs. Many of our patients are dedicated to helping us with our extensive research, and often participate in long-term disease progression studies and exclusive treatment trials.

At the Wien Center, we are constantly pursuing advances in diagnosing and treating Alzheimer’s disease and other memory disorders. In fact, our physicians have contributed to over 250 publications in peer-reviewed journals related to studies on aging, dementia, and clinical trials. Also, our studies are sponsored by the National Institute on Aging (NIA) federal agency and private pharmaceutical firms. While the primary focus of our research projects is early detection and diagnosis, our physicians are also conducting studies related to the following:

  • Neuroimaging to identify and diagnose conditions
  • Blood biomarkers for the diagnosis of Alzheimer’s disease and other dementias
  • Genetic components of memory disorders
  • New medication trials
  • How healthy aging differs from dementia
  • Ethnic and cultural differences among patients and how this impacts diagnosis and treatment of dementing conditions

We are also researching potential new diagnostic tools. For example, a blood plasma test may identify changes related to cognitive problems in post-COVID conditions. A new blood test for Alzheimer’s disease, which is currently only diagnosed through imaging studies and symptom presentation, shows great promise.

The Wien Center is highly dedicated to exchanging information and expanding knowledge between practitioners and the public and was the first established Alzheimer’s Disease Research Center (ADRC) in Florida: a nationwide network of 33 research facilities dedicated to developing novel testing and treatment methods for Alzheimer’s disease.

Mount Sinai Medical Center’s Wien Center is one of only two Florida locations where participants can register to be part of the Florida Brain Bank, a research program run by the ADRC network that coordinates the donation of brain tissues critical to studying Alzheimer’s disease and other dementias. It distributes donations to numerous clinical programs dedicated to the continued study of diagnosing and treating dementia statewide.

We are active partners in multiple research foundations and have hosted the annual Mild Cognitive Impairment (MCI) Symposium since 2003. The MCI Symposium includes a public forum to educate patients, caregivers, families, and the general public about Alzheimer’s disease, risk factors, prevention, and treatment.

We are also one of five partner organizations for the 1Florida Alzheimer’s Disease Research Center (1Florida ADRC), along with the University of Florida at Gainesville, the University of Miami, Florida International University, and Florida Atlantic University. The Wien Center supports 1Florida ADRC in research initiatives working toward a cure for Alzheimer’s disease and other dementias, as well as studies aimed at better understanding the biology and progression of dementia, testing new medications, and examining brain tissue donations.

Through these collaborations, our providers have access to the latest breakthroughs from other institutions. With the newest information in diagnosis and treatment options, the expert physicians at the Wien Center will provide patients with the most advanced medical care available and the opportunity to participate in clinical trials and other studies.

Our Physicians

Ranjan Duara, MD

Medical Director, Wien Center for Alzheimer’s Disease and Memory Disorders

  • Neurology
  • Neuroscience
  • Alzheimer’s Disease
  • Memory Disorders

Leonard L. Sokol, MD

  • Neurology
  • Neuroscience
  • Alzheimer’s Disease
  • Dementia
Back to top